# Raritan Pharmaceuticals, Inc. - Inspection Records

Source: https://www.keypedia.com/companies/raritan-pharmaceuticals-inc/31d76ce5-e5b2-4f61-b7b5-daa1a81f7cf0

> Inspection records and compliance data for Raritan Pharmaceuticals, Inc. in East Brunswick, New Jersey. Access full analysis and detailed observations.

---

## Details

- Name: Raritan Pharmaceuticals, Inc.
- FEI Number: 3004083931
- City: East Brunswick
- State: New Jersey
- Country Name: United States
- Address Line 1: 8 Joanna Ct
- Zip Code: 08816

## Related Documents

- [FDA Inspection 1250227 - Raritan Pharmaceuticals, Inc. - 2025-04-02](https://www.keypedia.com/records/fda_inspections/raritan-pharmaceuticals-inc/1a844f99-5473-4890-a8bf-2c8de0080187) — classification: Official Action Indicated (OAI), source: FDA, date: April 2, 2025
- [FDA Inspection 1037112 - Raritan Pharmaceuticals, Inc. - 2018-01-08](https://www.keypedia.com/records/fda_inspections/raritan-pharmaceuticals-inc/f275a0be-8cda-446f-9c15-5566f69959dc) — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 8, 2018
- [FDA Inspection 995165 - Raritan Pharmaceuticals, Inc. - 2016-10-20](https://www.keypedia.com/records/fda_inspections/raritan-pharmaceuticals-inc/779fe977-f104-48a2-84ec-2f8ccae976e3) — classification: Official Action Indicated (OAI), source: FDA, date: October 20, 2016
- [FDA Inspection 969785 - Raritan Pharmaceuticals, Inc. - 2016-04-14](https://www.keypedia.com/records/fda_inspections/raritan-pharmaceuticals-inc/4e1f0a76-f5de-436c-9de0-36541b294bdc) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 14, 2016
- [FDA Inspection 799355 - Raritan Pharmaceuticals, Inc. - 2012-09-19](https://www.keypedia.com/records/fda_inspections/raritan-pharmaceuticals-inc/af765194-be49-48aa-836e-424e9af61645) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 19, 2012
- [FDA Inspection 798953 - Raritan Pharmaceuticals, Inc. - 2012-08-21](https://www.keypedia.com/records/fda_inspections/raritan-pharmaceuticals-inc/03248a1a-d694-4d0b-b656-3e883d512301) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 21, 2012
- [FDA Inspection 725013 - Raritan Pharmaceuticals, Inc. - 2011-05-18](https://www.keypedia.com/records/fda_inspections/raritan-pharmaceuticals-inc/b722055c-307e-494d-af48-5f4110ad0bd2) — classification: No Action Indicated (NAI), source: FDA, date: May 18, 2011
- [FDA Inspection 624867 - Raritan Pharmaceuticals, Inc. - 2009-10-30](https://www.keypedia.com/records/fda_inspections/raritan-pharmaceuticals-inc/637257b3-a3e1-4321-946f-35cf0e7c1f7d) — classification: No Action Indicated (NAI), source: FDA, date: October 30, 2009

## Related Companies

- [Bayer Healthcare Pharmaceuticals Inc.](https://www.keypedia.com/companies/bayer-healthcare-pharmaceuticals-inc/ee43940d-d6bd-4b20-a758-d7ca5fbc322f)
- [Water-Jel Technologies, LLC](https://www.keypedia.com/companies/water-jel-technologies-llc/70ca8046-5140-4a07-a284-c14ea4d187e8)
- [Citra Labs, LLC](https://www.keypedia.com/companies/citra-labs-llc/e73ca079-a02c-47b0-8163-bcb23f4ee2c7)
- [Hobart Laboratories, Inc.](https://www.keypedia.com/companies/hobart-laboratories-inc/5c5a4597-1586-41c9-8113-eff78e2c2540)
- [I. Shay Cosmetics Inc](https://www.keypedia.com/companies/i-shay-cosmetics-inc/ca319860-96d1-4457-a29f-441806b9203e)
- [KAO USA Inc](https://www.keypedia.com/companies/kao-usa-inc/d8988e8b-a19d-48ba-beb6-a455d041293f)
- [DENTSPLY CAULK](https://www.keypedia.com/companies/dentsply-caulk/301ed493-53a8-4fd0-a03c-ae8707db6582)
- [Tangram Chemical LLC](https://www.keypedia.com/companies/tangram-chemical-llc/bce0ae7a-c03e-4d0a-9454-fb840cfd0cac)
- [American Blending & Filling Company, Inc.](https://www.keypedia.com/companies/american-blending-filling-company-inc/59e1e2ad-22f0-4315-9ee9-c3309d089d23)
- [Tergus Pharma LLC](https://www.keypedia.com/companies/tergus-pharma-llc/430c8a0d-2cd5-47b6-91af-d5573fd6bda3)